A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the ...

Five years after SARS-CoV-2 triggered a worldwide pandemic, leading to widespread devastation, another bat-borne coronavirus ...

When the SARS-CoV-2 virus enters the human body, it breaks into cells with the help of two proteins that it finds there, ACE2 and TMPRSS2. While there has been much discussion of viral infection in ...

from the discovery of the viral family in humans in the 1960s to the identification of SARS-CoV-2. Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in ...

SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). mRNA COVID-19 vaccines have been updated to the ...

In the graphics that follow, Scientific American presents detailed explanations, current as of mid-June, into how SARS-CoV-2 sneaks inside human cells, makes copies of itself and bursts out to ...

An AI-driven platform has been used to optimize an antibody, 3152-1142, to neutralize a wide range of SARS-CoV-2 variants, enhancing its potency against potential escape mutations.

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...